These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 5754750

  • 1. [Chemoprophylaxis and chemotherapy of hydatidiform mole].
    Marsiletti GC.
    Attual Ostet Ginecol; 1968; 1():52-75. PubMed ID: 5754750
    [No Abstract] [Full Text] [Related]

  • 2. [Chemotherapy in increasing excretion of gonadotropins following a mole pregnancy].
    Plate WP.
    Ned Tijdschr Verloskd Gynaecol; 1965 Oct; 65(5):360-3. PubMed ID: 5891348
    [No Abstract] [Full Text] [Related]

  • 3. [Medical treatment of vesicular mole].
    Attual Ostet Ginecol; 1967 Oct; 12(3):171-8. PubMed ID: 5627488
    [No Abstract] [Full Text] [Related]

  • 4. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
    Kim SJ, Na YJ, Jung SG, Kim CJ, Bae SN, Lee C.
    J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
    [Abstract] [Full Text] [Related]

  • 5. [Hydatidiform mole: advances-diagnosis-therapy].
    Grunstein S, Jaschevatzky OE, Shalit A.
    Prensa Med Argent; 1970 Jul 24; 57(21):1006-10. PubMed ID: 5478158
    [No Abstract] [Full Text] [Related]

  • 6. [Trophoblastic disease of post-molar malignant aspect: conservative uterine treatment by hypogastric perfusions of methotrexate in a 20-year-old woman].
    Bruniquel G.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966 Jul 24; 18(2):163-7. PubMed ID: 4288292
    [No Abstract] [Full Text] [Related]

  • 7. [Chemotherapy of villous tumors--with special reference to the effect of methotrexate therapy].
    Torigoe T, Moriwaki K, Yamasato Y, Kunishige T.
    Sanfujinka No Jissai; 1967 Mar 24; 16(3):267-71. PubMed ID: 5899925
    [No Abstract] [Full Text] [Related]

  • 8. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 24; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy in the treatment of undelivered hydatidiform mole. A study of 5 cases.
    Ma HK, Yip SK, Chun D.
    J Obstet Gynaecol Br Commonw; 1971 Jan 24; 78(1):80-6. PubMed ID: 5104985
    [No Abstract] [Full Text] [Related]

  • 10. Sclerosing encapsulating peritonitis and methotrexate.
    Sachdev A, Usatoff V, Thaow C.
    Aust N Z J Obstet Gynaecol; 2006 Feb 24; 46(1):58-9. PubMed ID: 16441697
    [No Abstract] [Full Text] [Related]

  • 11. Ocular irritation from low-dose methotrexate.
    Hussain MI.
    Cancer; 1982 Aug 01; 50(3):605. PubMed ID: 7201342
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Hoffman MS, Fiorica JV, Gleeson NC, Roberts WS, Cavanagh D.
    Gynecol Oncol; 1996 Feb 01; 60(2):292-4. PubMed ID: 8631554
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul 01; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.